These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11328801)

  • 1. Distribution of mef(A) and erm(B) genes in macrolide-resistant blood isolates of viridans group streptococci.
    Rodríguez-Avial I; Rodríguez-Avial C; Culebras E; Benítez A; Picazo JJ
    J Antimicrob Chemother; 2001 May; 47(5):727-8. PubMed ID: 11328801
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of macrolide-resistant genes in group C and G streptococci].
    Seral C; González V; Castillo J; García C; Rubio MC; Gómez-Lus R
    Rev Esp Quimioter; 2000 Jun; 13(2):171-5. PubMed ID: 10918090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of macrolide resistance in beta-haemolytic streptococci of Lancefield groups A, B, C and G and evidence for a new mef element in group G streptococci that carries allelic variants of mef and msr(D).
    Amezaga MR; McKenzie H
    J Antimicrob Chemother; 2006 Mar; 57(3):443-9. PubMed ID: 16431859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.
    Sangvik M; Littauer P; Simonsen GS; Sundsfjord A; Dahl KH
    J Antimicrob Chemother; 2005 Nov; 56(5):841-6. PubMed ID: 16172106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes.
    Cascone C; Santagati M; Noviello S; Iannelli F; Esposito S; Pozzi G; Stefani S
    Microb Drug Resist; 2002; 8(2):129-32. PubMed ID: 12118517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae.
    Cerdá Zolezzi P; Laplana LM; Calvo CR; Cepero PG; Erazo MC; Gómez-Lus R
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3462-7. PubMed ID: 15328112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of macrolide resistance in clinical group B streptococci isolated in France.
    Fitoussi F; Loukil C; Gros I; Clermont O; Mariani P; Bonacorsi S; Le Thomas I; Deforche D; Bingen E
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1889-91. PubMed ID: 11353645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].
    Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ
    Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.
    Hoban DJ; Wierzbowski AK; Nichol K; Zhanel GG
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2147-50. PubMed ID: 11408241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C; van der Linden M; Reinert RR
    Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group.
    Jacobs JA; van Baar GJ; London NH; Tjhie JH; Schouls LM; Stobberingh EE
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2375-7. PubMed ID: 11451701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low rate of carriage of macrolide-resistant group B streptococci in pregnant women in The Netherlands.
    Muller AE; Valkenburg-van den Berg AW; Kreft D; Oostvogel PM; Sprij AJ; van Belkum A
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):17-20. PubMed ID: 17482748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada.
    Weiss K; De Azavedo J; Restieri C; Galarneau LA; Gourdeau M; Harvey P; Paradis JF; Salim K; Low DE
    J Antimicrob Chemother; 2001 Mar; 47(3):345-8. PubMed ID: 11222568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
    Van Eldere J; Meekers E; Lagrou K; Massonet C; Canu A; Devenyns I; Verhaegen J; Syrogiannopoulos G; Leclercq R
    Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
    Ergin A; Ercis S; Hasçelik G
    J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes.
    Cerdá Zolezzi P; Rubio Calvo MC; Millán L; Goñi P; Canales M; Capilla S; Durán E; Gómez-Lus R
    Int J Antimicrob Agents; 2004 Jun; 23(6):582-9. PubMed ID: 15194129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
    Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
    Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era.
    Daikos GL; Koutsolioutsou A; Tsiodras S; Theodoridou M; Koutouzis EI; Charissiadou A; Pangalis A; Michos AG; Chaidopoulou F; Braoudaki M; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):393-8. PubMed ID: 18077121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.